Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-009876
Filing Date
2021-08-12
Accepted
2021-08-12 13:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27692
2 filename2.txt TEXT-EXTRACT 1525
  Complete submission text file 0000000000-21-009876.txt   40277
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filed for) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations